Treatment of hepatocellular carcinoma with adenoviral vector-mediated Flt3 ligand gene therapy
Hao Wang(Fujian Medical University), Yajun Guo(Eastern Hepatobiliary Surgery Hospital), Hongxun Sang(Third Affiliated Hospital of Southern Medical University), Shilin Yang(Second Military Medical University), Weizhu Qian(Institute of Molecular and Cell Biology), Rongfu Wang(University of Southern California), Qing Yang(Guangzhou University of Chinese Medicine), Jing Ma(Shanghai University), Xiaoqiang Fan(Second Military Medical University), Jianxin Dai(Liaocheng University), Jian Zhao(Second Military Medical University), Sheng Hou(Second Military Medical University), Bohua Li(Sichuan University)
Cited by 7
Related Papers
Sumoylation Promotes the Stability of the DNA Sensor cGAS and the Adaptor STING to Regulate the Kinetics of Response to DNA Virus
|Immunity|2016|378
Hepatitis B virus X protein represses miRNA-148a to enhance tumorigenesis
|Journal of Clinical Investigation|2013|249
Safety, Activity, and Biomarkers of SHR-1210, an Anti-PD-1 Antibody, for Patients with Advanced Esophageal Carcinoma
|Clinical Cancer Research|2018|218